Anlon Healthcare

{
  "main_header": {
    "sid": 10039733,
    "name": "Anlon Healthcare",
    "stock_name": "Anlon Healthcare",
    "full_name": "Anlon Healthcare Ltd",
    "name_url": "stocks-analysis/anlon-healthcare",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "14.53",
    "chg": 0.3,
    "chgp": "2.11%",
    "dir": 1,
    "prev_price": "14.23",
    "mcapval": "751.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 544497,
    "symbol": "AHCL",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE0Y8W01025",
    "curr_date": "Aug 07, 03:30 PM",
    "curr_time": "04:34 AM",
    "last_traded_at": "Aug 07, 03:30 PM IST",
    "bse_nse_vol": "34.31 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 07, 2026",
    "traded_date_str": "2026 08 07",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/anlon-healthcare-10039733-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Anlon Healthcare Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/anlon-healthcare-ltd-is-rated-sell-4141654",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AnlonHealthcare_mojoScore_4141654.png",
        "date": "2026-08-07 10:10:41",
        "description": "Anlon Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Anlon Healthcare Ltd Falls 2.60%: 4 Key Factors Driving the Weekly Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/anlon-healthcare-ltd-falls-260-4-key-factors-driving-the-weekly-decline-4130972",
        "imagepath": "",
        "date": "2026-08-01 09:04:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Jul:</strong> Stock surges 4.93% amid bullish technical momentum</p>\n                    <p><strong>28 Jul:</strong> Technical momentum confirmed bullish despite slight price dip</p>\n                    <p><strong>30 Jul:</strong> Quarterly results reveal profit decline despite revenue growth; stock plunges 8.50%</p>\n                    <p><strong>31 Jul:</strong> Technical momentum shifts to mildly bullish amid market pressure; stock closes marginally higher</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.15.01</div></div>\n                    <div cl..."
      },
      {
        "title": "Anlon Healthcare Ltd Technical Momentum Shifts Amid Market Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/anlon-healthcare-ltd-technical-momentum-shifts-amid-market-pressure-4129624",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AnlonHealthcare_technicaldot_4129624.png",
        "date": "2026-07-31 08:03:22",
        "description": "Anlon Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum as recent market activity reflects increased selling pressure. Despite some mildly bullish technical indicators, the stock’s price has declined sharply, prompting a downgrade in its Mojo Grade from Hold to Sell as of 1 June 2026."
      },
      {
        "title": "Are Anlon Healthcare Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-anlon-healthcare-ltd-latest-results-good-or-bad-4129106",
        "imagepath": "",
        "date": "2026-07-30 19:23:50",
        "description": "Anlon Healthcare Ltd's latest financial results for Q1 FY27 reveal a significant contrast between robust revenue growth and a notable decline in profitability. The company reported net sales of ₹87.56 crores, reflecting a year-on-year growth of 78.95%, indicating successful market penetration or potential new product launches. However, this impressive topline expansion came at the expense of profitability, as net profit fell to ₹6.66 crores, down 60% year-on-year. \n\nThe operating margin also experienced a substantial contraction, decreasing from 30.05% in the previous quarter to 17.80%, while the PAT margin dropped from 21.75% to 9.46%. This margin compression raises concerns about the sustainability of the company's growth, suggesting that the aggressive revenue increase may be linked to factors such as elevated raw material costs or pricing strategies aimed at gaining market share.\n\nAdditionally, Anlon He..."
      },
      {
        "title": "Anlon Healthcare Q1 FY27: Revenue Surge Masks Profitability Concerns as Margins Contract Sharply",
        "link": "https://www.marketsmojo.com/news/result-analysis/anlon-healthcare-q1-fy27-revenue-surge-masks-profitability-concerns-as-margins-contract-sharply-4129008",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AnlonHealthcare_quaterlyResult_4129008.png",
        "date": "2026-07-30 17:17:13",
        "description": "Anlon Healthcare Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹825.00 crores, delivered a mixed performance in Q1 FY27, posting consolidated net profit of ₹6.66 crores—a sharp decline of 36.57% quarter-on-quarter and a concerning 60.00% year-on-year drop. Despite impressive topline growth of 72.06% QoQ, the company's profitability came under severe pressure as operating margins contracted dramatically from 30.05% to 17.80%, raising questions about the sustainability of its recent expansion drive. The stock tumbled 8.50% following the results, closing at ₹14.54 on July 30, 2026, reflecting investor disappointment over deteriorating profit quality."
      },
      {
        "title": "Anlon Healthcare Ltd Reports Decline in Quarterly Profit Amid Revenue Growth",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/anlon-healthcare-ltd-reports-decline-in-quarterly-profit-amid-revenue-growth-4128947",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AnlonHealthcare_fintrenddot_4128947.png",
        "date": "2026-07-30 16:00:13",
        "description": "Anlon Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a notable shift in its financial trend for the quarter ended June 2026. Despite a robust 33.18% growth in net sales over the nine-month period, the company’s quarterly profitability has deteriorated, signalling challenges ahead for investors and analysts alike."
      },
      {
        "title": "When is the next results date for Anlon Healthcare Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-anlon-healthcare-ltd-4124821",
        "imagepath": "",
        "date": "2026-07-28 23:17:55",
        "description": "The next results date for Anlon Healthcare Ltd is scheduled for 30 July 2026...."
      },
      {
        "title": "Anlon Healthcare Ltd Technical Momentum Shifts to Bullish Amid Micro-Cap Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/anlon-healthcare-ltd-technical-momentum-shifts-to-bullish-amid-micro-cap-surge-4123518",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AnlonHealthcare_technicaldot_4123518.png",
        "date": "2026-07-28 08:06:39",
        "description": "Anlon Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underpinned by improvements across key technical indicators including MACD, moving averages, and Bollinger Bands, signalling potential upside for investors amid a mixed broader market environment."
      },
      {
        "title": "Anlon Healthcare Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/anlon-healthcare-ltd-is-rated-hold-by-marketsmojo-4122238",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AnlonHealthcare_mojoScore_4122238.png",
        "date": "2026-07-27 10:11:24",
        "description": "Anlon Healthcare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 27 July 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      }
    ],
    "total": 20,
    "sid": "10039733",
    "stock_news_url": "https://www.marketsmojo.com/news/anlon-healthcare-10039733"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements",
      "datetime": "08-Aug-2026",
      "details": "Anlon Healthcare Limited has informed the exchange about the Share Swap Agreement (\"SSA\").",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Approve Notice Of 13Th Annual General Meeting Of The Company",
      "datetime": "06-Aug-2026",
      "details": "Anlon Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve the transaction mentioned in Prior Intimation of Board Meeting.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "06-Aug-2026",
      "details": "We have attached herewith intimation as per Reg. 30 of SEBI (LODR) Regulation 2015.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Anlon Healthcare Ltd has announced <strong>2:10</strong> stock split, ex-date: 24 Apr 26",
          "dt": "2026-04-24",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Anlon Healthcare Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 24 Apr 26",
          "dt": "2026-04-24",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Anlon Healthcare Ltd is Rated Sell

2026-08-07 10:10:41

Anlon Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Anlon Healthcare Ltd Falls 2.60%: 4 Key Factors Driving the Weekly Decline

2026-08-01 09:04:04

Key Events This Week

27 Jul: Stock surges 4.93% amid bullish technical momentum

28 Jul: Technical momentum confirmed bullish despite slight price dip

30 Jul: Quarterly results reveal profit decline despite revenue growth; stock plunges 8.50%

31 Jul: Technical momentum shifts to mildly bullish amid market pressure; stock closes marginally higher

Week Open

Rs.15.01

Read full news article

Anlon Healthcare Ltd Technical Momentum Shifts Amid Market Pressure

2026-07-31 08:03:22

Anlon Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum as recent market activity reflects increased selling pressure. Despite some mildly bullish technical indicators, the stock’s price has declined sharply, prompting a downgrade in its Mojo Grade from Hold to Sell as of 1 June 2026.

Read full news article

Are Anlon Healthcare Ltd latest results good or bad?

2026-07-30 19:23:50

Anlon Healthcare Ltd's latest financial results for Q1 FY27 reveal a significant contrast between robust revenue growth and a notable decline in profitability. The company reported net sales of ₹87.56 crores, reflecting a year-on-year growth of 78.95%, indicating successful market penetration or potential new product launches. However, this impressive topline expansion came at the expense of profitability, as net profit fell to ₹6.66 crores, down 60% year-on-year. The operating margin also experienced a substantial contraction, decreasing from 30.05% in the previous quarter to 17.80%, while the PAT margin dropped from 21.75% to 9.46%. This margin compression raises concerns about the sustainability of the company's growth, suggesting that the aggressive revenue increase may be linked to factors such as elevated raw material costs or pricing strategies aimed at gaining market share. Additionally, Anlon He...

Read full news article

Anlon Healthcare Q1 FY27: Revenue Surge Masks Profitability Concerns as Margins Contract Sharply

2026-07-30 17:17:13

Anlon Healthcare Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹825.00 crores, delivered a mixed performance in Q1 FY27, posting consolidated net profit of ₹6.66 crores—a sharp decline of 36.57% quarter-on-quarter and a concerning 60.00% year-on-year drop. Despite impressive topline growth of 72.06% QoQ, the company's profitability came under severe pressure as operating margins contracted dramatically from 30.05% to 17.80%, raising questions about the sustainability of its recent expansion drive. The stock tumbled 8.50% following the results, closing at ₹14.54 on July 30, 2026, reflecting investor disappointment over deteriorating profit quality.

Read full news article

Anlon Healthcare Ltd Reports Decline in Quarterly Profit Amid Revenue Growth

2026-07-30 16:00:13

Anlon Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a notable shift in its financial trend for the quarter ended June 2026. Despite a robust 33.18% growth in net sales over the nine-month period, the company’s quarterly profitability has deteriorated, signalling challenges ahead for investors and analysts alike.

Read full news article

When is the next results date for Anlon Healthcare Ltd?

2026-07-28 23:17:55

The next results date for Anlon Healthcare Ltd is scheduled for 30 July 2026....

Read full news article

Anlon Healthcare Ltd Technical Momentum Shifts to Bullish Amid Micro-Cap Surge

2026-07-28 08:06:39

Anlon Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underpinned by improvements across key technical indicators including MACD, moving averages, and Bollinger Bands, signalling potential upside for investors amid a mixed broader market environment.

Read full news article

Anlon Healthcare Ltd is Rated Hold by MarketsMOJO

2026-07-27 10:11:24

Anlon Healthcare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 27 July 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

View All News